Chromosome Instability and Progression in Urothelial Cell Carcinoma of the Bladder

References

• Prat E. Bernues M, Caballin MR, et al. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 2001; 57: 9 86–92.
   PubMed Web of Science ®Google Scholar
• Cahill DP Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392: 300–3.
   PubMed Web of Science ®Google Scholar
• Baretton GB, Vogt T, Blasenbreu S, Lohrs U. Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Hum Pathol 1994:25: 506–13.
   PubMed Web of Science ®Google Scholar
• Chanvitan A, Pultawibul P, Carsson AG. Flow cytometry in squamous cell esophageal cancer and precancerous lesions. Dis Esophagus 1997: 10: 206–10.
   Google Scholar
• Cianciulli AM, Bovani R, Leonardo F, et al. Interphase cytogenetics of bladder cancer progression: relationship be-tween aneusomy, DNA ploidy pattern, histopathology and clinical outcome. Int J Chin Res 2000; 30: 5–11.
   Google Scholar
• Sandberg AA. Chromosome abnormalities in human cancer and leukaemia. Mutat Res 1991; 247: 231–40.
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Berger CS. Review of chromosome studies in urological tumours. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 1994; 151: 545–60
   Google Scholar
• Orlow I, Lianes P, Lacombe L, et al. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumours. Cancer Res 1994; 54: 2848-5 1.
   PubMed Web of Science ®Google Scholar
• Cairns P, Shaw ME, Knowles MA. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromo-some 9. Oncogene 1993; 8: 1083–5.
   Google Scholar
• Waldman FM, Carrol PR, Kerschmann R, et al. Centromeric copy of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 1991; 51: 3807–13.
   PubMed Web of Science ®Google Scholar
• Spruck III C, Ohneseit P, Zulueta M, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;5 4:7 84–8.
   Google Scholar
• Neuhaus M, Wagner U, Schmid U. et al. Polysemies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer. Hum Pathol 1999; 30: 81–6.
   Google Scholar
• Mostofi FK. Sorbin LH, Torloni H. Histological typing of urinary bladder tumours. International Histological Classifica-tion of Tumours. World Health Organization. Geneva. 1973.
   Google Scholar
• AJCC Cancer Staging Manual. American Joint Committee on Cancer. 5th ed. Philadelphia; Lippincott-Raven; 1997.
   Google Scholar
• Santos L, Pereira S, Cardoso F, et al. Genetic alterations in primary transitional cell carcinoma of the bladder and its recurrences. Ann Oncol 2000; 80 (Suppl 4).
   Google Scholar
• Matsuyama H, Pan Y. May E. et al. p53 deletion as a genetic marker in urothelial tumour by fluorescence in situ hybridiza-tion. Cancer Res 1994; 54: 6057–60.
   Google Scholar
• Shii N. Ariyoshi A, Kinjo M, Sasaki K. Detection of numerical chromosomal aberrations in bladder carcinomas by fluores-cence in situ hybridization. J Urol Pathol 1997; 7: 21–32.
   Google Scholar
• Hartmann A, Rosner II Schlake G, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carci-noma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 2000; 80: 709^ 18.
   PubMed Web of Science ®Google Scholar
• Park WS, Oh MJ, Lee HK, et al. Deletion of 9p21 and TP53 in bladder cancer. J Korean Med Sci 1996; 11: 233–8.
   PubMedGoogle Scholar
• Walters AD. Ballantvne AS, Going JJ, et al. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. Br J Urol Int 2000; 85: 42–7.
   Google Scholar
• Fadl-Elmura I, Gorunova L, Mandahl N, et al. Karyotypic characterization of urinary bladder transitional cell carcinoma. Genes Chromos Cancer 2000; 29: 256–65.
   Google Scholar
• On-Weaver TL, Weinberg RA. A checkpoint on the road to cancer. Nature 1998; 392: 223–4.
   Google Scholar
• Hernando E. Orlow 1, Liberal V, et al. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int J Cancer 2001; 20: 223–7.
   Google Scholar
• Olesen SH, Thykjaer T, Orntoft TF. Mitotic checkpoint genes hBUB1, hBUBIB, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogen-esis 2001; 22: 813–5.
   Google Scholar
• Kramer A. Neben K, Ho AD. Centrosome replication. genomic instability and cancer. Leukemia 2002; 16: 767–75.
   Google Scholar
• Lung J-C, Chu J-S, Yu J-C, et al. Aberrant expression of cell-cycle regulator cyclin DI in breast cancer is related to chromosomal genomic instability. Genes Chromos Cancer 2002; 34: 276–84.
   Google Scholar
• Dahse R, Utting M. Werner W. et al. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples, J Oncol 2002:20: 107–15.
   Google Scholar